Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: June 3, 2023

Novitium Pharma Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for NOVITIUM PHARMA, and what generic and branded alternatives to NOVITIUM PHARMA drugs are available?

NOVITIUM PHARMA has fifty-seven approved drugs.

There is one tentative approval on NOVITIUM PHARMA drugs.

Summary for Novitium Pharma

US Patents:	0
Tradenames:	53
Ingredients:	52
NDAs:	57

Drugs and US Patents for Novitium Pharma

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novitium Pharma	LIDOCAINE HYDROCHLORIDE	lidocaine hydrochloride	SOLUTION;TOPICAL	216250-001	Mar 23, 2022	AT	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Novitium Pharma	NAPROXEN	naproxen	SUSPENSION;ORAL	211910-001	Mar 10, 2021	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Novitium Pharma	ACETAZOLAMIDE	acetazolamide	TABLET;ORAL	210588-001	Oct 17, 2019	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Novitium Pharma	RANITIDINE HYDROCHLORIDE	ranitidine hydrochloride	CAPSULE;ORAL	210681-001	Nov 23, 2018		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Novitium Pharma	RANITIDINE HYDROCHLORIDE	ranitidine hydrochloride	CAPSULE;ORAL	210681-002	Nov 23, 2018		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Novitium Pharma

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Baxter

Boehringer Ingelheim

Dow

Medtronic

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.